NmVac4-A/C/Y/W-135
http://dbpedia.org/resource/NmVac4-A/C/Y/W-135 an entity of type: Thing
NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics.
rdf:langString
rdf:langString
NmVac4-A/C/Y/W-135
xsd:integer
20547586
xsd:integer
1101519541
rdf:langString
polysaccharide
rdf:langString
AH04
rdf:langString
J07
rdf:langString
none
rdf:langString
C
rdf:langString
Intramuscular
rdf:langString
Neisseria meningitidis A,C,Y,W-135
rdf:langString
vaccine
rdf:langString
changed
xsd:integer
444518343
xsd:integer
50
rdf:langString
NmVac4-A/C/Y/W-135 is the commercial name of the polysaccharide vaccine against the bacterium (specifically serogroups A, C, Y, and W-135) that causes meningococcal meningitis. The product, by JN-International Medical Corporation, is designed and formulated to be used in developing countries for protecting populations during meningitis disease epidemics. Meningococcal meningitis is a bacterial infection caused by the bacterium Neisseria meningitidis, also known as meningococcus. The vaccine is made from bacterial capsular polysaccharides through fermentation of each individual serogroup of Neisseria meningitidis in bioreactors. After fermentation, the polysaccharides are purified, formulated, and lyophilized using preservatives and stabilizers to make a vaccine product. The vaccine cannot protect from other serogroups of N. meningitidis and cannot eliminate the chance of infection by these serogroups.
xsd:nonNegativeInteger
22944